{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T14:12:51Z","timestamp":1762265571692,"version":"build-2065373602"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003704","name":"Korea Research Institute of Chemical Technology","doi-asserted-by":"publisher","award":["KK2432-10","BSK22-414"],"award-info":[{"award-number":["KK2432-10","BSK22-414"]}],"id":[{"id":"10.13039\/501100003704","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ejmech.2025.117430","type":"journal-article","created":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T01:45:24Z","timestamp":1740275124000},"page":"117430","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Development of sulfamoylbenzamide-based capsid assembly modulators for hepatitis B virus capsid assembly"],"prefix":"10.1016","volume":"290","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-0575-0432","authenticated-orcid":false,"given":"Syed Azeem","family":"Abbas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyeon-Min","family":"Cha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7433-445X","authenticated-orcid":false,"given":"Sandesha","family":"Nayak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sujin","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3348-8275","authenticated-orcid":false,"given":"Jayaraj","family":"Gowda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilva","family":"Lieknina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andris","family":"Dislers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2665-9431","authenticated-orcid":false,"given":"In Su","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inseong","family":"Jo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meehyein","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6797-2360","authenticated-orcid":false,"given":"Hyejin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6512-1602","authenticated-orcid":false,"given":"Chunkyu","family":"Ko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7831-1832","authenticated-orcid":false,"given":"Soo Bong","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.117430_bib1","series-title":"Guidelines for the Prevention, Diagnosis, Care and Treatment for People with Chronic Hepatitis B Infection","first-page":"1","author":"Zhao","year":"2024"},{"key":"10.1016\/j.ejmech.2025.117430_bib2","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.3390\/jcm11051349","article-title":"Capsid assembly modulators as antiviral agents against HBV: molecular mechanisms and clinical perspectives","volume":"11","author":"Taverniti","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ejmech.2025.117430_bib3","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/S0140-6736(14)60220-8","article-title":"Hepatitis B virus infection","volume":"384","author":"Tr\u00e9po","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2025.117430_bib4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.coviro.2021.04.009","article-title":"Hepatitis B virus\u2013host interactions and Novel targets for viral cure","volume":"49","author":"Ligat","year":"2021","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.ejmech.2025.117430_bib5","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1056\/NEJMoa040431","article-title":"Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B","volume":"351","author":"Marcellin","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2025.117430_bib6","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.bmcl.2017.01.010","article-title":"Synthesis and antiviral evaluation of Novel heteroarylpyrimidines analogs as HBV capsid effectors","volume":"27","author":"Boucle","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.117430_bib7","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/s41573-019-0037-0","article-title":"Therapeutic strategies for hepatitis B virus infection: towards a cure","volume":"18","author":"Fanning","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2025.117430_bib8","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1016\/j.cgh.2023.02.032","article-title":"New perspectives on development of curative strategies for chronic hepatitis B","volume":"21","author":"Feld","year":"2023","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejmech.2025.117430_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7554\/eLife.00049","article-title":"Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus","volume":"1","author":"Yan","year":"2012","journal-title":"Elife"},{"key":"10.1016\/j.ejmech.2025.117430_bib10","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/s41586-022-04857-0","article-title":"Structural insights into the HBV receptor and bile acid transporter NTCP","volume":"606","author":"Park","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2025.117430_bib11","first-page":"1","article-title":"Structural basis for nuclear import of hepatitis B virus (HBV) nucleocapsid core","volume":"10","author":"Yang","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ejmech.2025.117430_bib12","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.3390\/v13081463","article-title":"Mechanism of hepatitis B virus cccDNA formation","volume":"13","author":"Wei","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.ejmech.2025.117430_bib13","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1136\/gutjnl-2015-309809","article-title":"HBV cccDNA: viral persistence reservoir and key obstacle for a cure of chronic hepatitis B","volume":"64","author":"Nassal","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.ejmech.2025.117430_bib14","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.antiviral.2015.06.020","article-title":"Core protein: a pleiotropic keystone in the HBV lifecycle","volume":"121","author":"Zlotnick","year":"2015","journal-title":"Antiviral Res"},{"key":"10.1016\/j.ejmech.2025.117430_bib15","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.3390\/v15122367","article-title":"Recent advances in the development of sulfamoyl-based hepatitis B virus nucleocapsid assembly modulators","volume":"15","author":"Nayak","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.ejmech.2025.117430_bib16","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.antiviral.2017.11.015","article-title":"The diverse functions of the hepatitis B core\/capsid protein (HBc) in the viral life cycle: implications for the development of HBc-targeting antivirals","volume":"149","author":"Diab","year":"2018","journal-title":"Antiviral Res"},{"key":"10.1016\/j.ejmech.2025.117430_bib17","doi-asserted-by":"crossref","first-page":"42374","DOI":"10.1038\/srep42374","article-title":"Heteroaryldihydropyrimidine (HAP) and sulfamoylbenzamide (SBA) inhibit hepatitis B virus replication by different molecular mechanisms","volume":"7","author":"Zhou","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2025.117430_bib18","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41467-023-36219-3","article-title":"Molecular elucidation of drug-induced abnormal assemblies of the hepatitis B virus capsid protein by solid-state NMR","volume":"14","author":"Lecoq","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2025.117430_bib19","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/s41575-022-00700-z","article-title":"Nomenclature of HBV core protein-targeting antivirals","volume":"19","author":"Zoulim","year":"2022","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejmech.2025.117430_bib20","doi-asserted-by":"crossref","first-page":"7420","DOI":"10.3390\/molecules26247420","article-title":"Current progress in the development of hepatitis B virus capsid assembly modulators: chemical structure, mode-of-action and efficacy","volume":"26","author":"Kim","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.117430_bib21","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1053\/j.gastro.2018.12.023","article-title":"Antiviral activity, safety, and pharmacokinetics of capsid assembly modulator NVR 3-778 in patients with chronic HBV infection","volume":"156","author":"Yuen","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejmech.2025.117430_bib22","doi-asserted-by":"crossref","first-page":"S129","DOI":"10.1016\/S0168-8278(20)30773-X","article-title":"Efficacy and safety results of the phase 2 JNJ-56136379 JADE study in patients with chronic hepatitis B: interim week 24 data","volume":"73","author":"Janssen","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejmech.2025.117430_bib23","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01734-18","article-title":"Preclinical characterization of NVR 3-778, a first-in-class capsid assembly modulator against hepatitis B virus","volume":"63","author":"Lam","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2025.117430_bib24","doi-asserted-by":"crossref","first-page":"106192","DOI":"10.1016\/j.bioorg.2022.106192","article-title":"Design, synthesis, and biological evaluation of Novel sulfamoylbenzamide derivatives as HBV capsid assembly modulators","volume":"129","author":"Wang","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.117430_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2021.105080","article-title":"Identification of hepatitis B virus core protein residues critical for capsid assembly, pgRNA encapsidation and resistance to capsid assembly modulators","volume":"191","author":"Luo","year":"2021","journal-title":"Antiviral Res"},{"key":"10.1016\/j.ejmech.2025.117430_bib26","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3851\/IMP2938","article-title":"HBV carrying drug-resistance mutations in chronically infected treatment-naive patients","volume":"20","author":"Gomes-Gouv\u00eaa","year":"2014","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.ejmech.2025.117430_bib27","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1021\/acsmedchemlett.9b00550","article-title":"Discovery of a new sulfonamide hepatitis B capsid assembly modulator","volume":"11","author":"Na","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.117430_bib28","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1021\/acsmedchemlett.0c00606","article-title":"Sulfamoylbenzamide-based capsid assembly modulators for selective inhibition of hepatitis B viral replication","volume":"12","author":"Lee","year":"2021","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.117430_bib29","doi-asserted-by":"crossref","first-page":"6247","DOI":"10.1021\/acs.jmedchem.8b00654","article-title":"Synthesis and evaluation of N-Phenyl-3-Sulfamoyl-Benzamide derivatives as capsid assembly modulators inhibiting hepatitis B virus (HBV)","volume":"61","author":"Vandyck","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117430_bib30","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1099\/vir.0.004861-0","article-title":"Persistence of the hepatitis B virus covalently closed circular DNA in HepaRG human hepatocyte-like cells","volume":"90","author":"Hantz","year":"2009","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.ejmech.2025.117430_bib31","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.jhep.2018.08.012","article-title":"Hepatitis B Virus Genome Recycling and de novo Secondary Infection Events Maintain Stable cccDNA Levels","volume":"69","author":"Ko","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejmech.2025.117430_bib32","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.3390\/v15051195","article-title":"Canocapavir is a Novel capsid assembly modulator inducing a conformational change of the linker region of HBV core protein","volume":"15","author":"Zheng","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.ejmech.2025.117430_bib33","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00835-18","article-title":"Novel potent capsid assembly modulators regulate multiple steps of the hepatitis B virus life cycle","volume":"62","author":"Lahlali","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2025.117430_bib34","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02439-19","article-title":"Antiviral properties and mechanism of action studies of the hepatitis B virus capsid assembly modulator JNJ-56136379, antimicrob","volume":"64","author":"Berke","year":"2020","journal-title":"Agents Chemother."},{"key":"10.1016\/j.ejmech.2025.117430_bib35","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.str.2013.06.013","article-title":"Assembly-directed antivirals differentially bind quasiequivalent pockets to modify hepatitis B virus capsid tertiary and quaternary structure","volume":"21","author":"Katen","year":"2013","journal-title":"Structure"},{"key":"10.1016\/j.ejmech.2025.117430_bib36","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"Gromacs: high performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1\u20132","author":"Abraham","year":"2015","journal-title":"SoftwareX"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425001953?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425001953?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T14:07:37Z","timestamp":1762265257000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425001953"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":36,"alternative-id":["S0223523425001953"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117430","relation":{},"ISSN":["0223-5234"],"issn-type":[{"type":"print","value":"0223-5234"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of sulfamoylbenzamide-based capsid assembly modulators for hepatitis B virus capsid assembly","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117430","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"117430"}}